The involvement of adiponectin signalling is further supported by evidence that pharmacological activation via AdipoRon, a selective AdipoRs agonist, alleviates depression- and anxiety-like behaviours and enhances hippocampal plasticity [26,175]. This evidence concerns the gene ADIPOQ and depressive disorder.